LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
This Quarter Return
-0.87%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$3.6B
AUM Growth
+$3.6B
(+51%)
Cap. Flow
+$1.29B
Cap. Flow
% of AUM
35.88%
Top 10 Holdings %
Top 10 Hldgs %
41.33%
Holding
429
New
62
Increased
58
Reduced
52
Closed
147
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$186M |
| 2 |
Amazon
AMZN
|
$149M |
| 3 |
Microsoft
MSFT
|
$145M |
| 4 |
Target
TGT
|
$116M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$108M |
Top Sells
| 1 |
Warner Bros
WBD
|
$213M |
| 2 |
Lowe's Companies
LOW
|
$159M |
| 3 |
T-Mobile US
TMUS
|
$118M |
| 4 |
BLU
BELLUS Health Inc.
BLU
|
$39.2M |
| 5 |
Texas Instruments
TXN
|
$37.5M |
Sector Composition
| 1 | Healthcare | 17.93% |
| 2 | Communication Services | 17.3% |
| 3 | Financials | 14.67% |
| 4 | Technology | 14.6% |
| 5 | Consumer Discretionary | 14.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Advanced Micro Devices
AMD
$263B
| $6.49M | 0.04% |
102,450
+80,300
| +363% | +$5.09M |
|
77
American Express
AXP
$225B
| $6.45M | 0.04% |
47,814
+43,319
| +964% | +$5.84M |
|
78
Pyxis Oncology
PYXS
$91.2M
| $6.25M | 0.04% |
3,170,803
| – | – |
|
79
PepGen
PEPG
$39M
| $6.03M | 0.04% |
664,516
| – | – |
|
80
Autodesk
ADSK
$67.9B
| $5.93M | 0.04% |
+31,742
| New | +$5.93M |
|
81
Rallybio
RLYB
$24.1M
| $5.82M | 0.03% |
402,000
| – | – |
|
82
FedEx
FDX
$53.2B
| $5.73M | 0.03% |
38,617
+38,582
| +110,234% | +$5.73M |
|
|
CBAY
83
DELISTED
Cymabay Therapeutics
CBAY
| $5.66M | 0.03% |
1,615,900
+40,631
| +3% | +$142K |
|
84
Prologis
PLD
$103B
| $5.28M | 0.03% |
+52,000
| New | +$5.28M |
|
85
Ross Stores
ROST
$49.3B
| $5.12M | 0.03% |
60,776
+8,371
| +16% | +$705K |
|
86
Aldeyra Therapeutics
ALDX
$350M
| $5.11M | 0.03% |
956,900
-14,881
| -2% | -$79.5K |
|
87
KalVista Pharmaceuticals
KALV
$713M
| $5.04M | 0.03% |
347,125
-122,875
| -26% | -$1.78M |
|
88
Simon Property Group
SPG
$58.7B
| $5M | 0.03% |
+55,745
| New | +$5M |
|
89
Centene
CNC
$14.8B
| $4.72M | 0.03% |
+60,619
| New | +$4.72M |
|
90
Biomea Fusion
BMEA
$114M
| $4.2M | 0.02% |
429,400
+9,251
| +2% | +$90.5K |
|
91
RTX Corp
RTX
$212B
| $4.17M | 0.02% |
+50,960
| New | +$4.17M |
|
92
Moody's
MCO
$89B
| $4.16M | 0.02% |
+17,110
| New | +$4.16M |
|
93
Equinix
EQIX
$74.6B
| $4.06M | 0.02% |
+7,141
| New | +$4.06M |
|
94
lululemon athletica
LULU
$23.8B
| $4.04M | 0.02% |
14,467
| – | – |
|
|
MBAC.U
95
DELISTED
M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant
MBAC.U
| $3.94M | 0.02% |
400,000
| – | – |
|
96
Medtronic
MDT
$118B
| $3.9M | 0.02% |
+48,253
| New | +$3.9M |
|
97
Scholar Rock
SRRK
$3.3B
| $3.84M | 0.02% |
553,700
-8,482
| -2% | -$58.8K |
|
98
GH Research
GHRS
$870M
| $3.66M | 0.02% |
314,930
| – | – |
|
99
HDFC Bank
HDB
$181B
| $3.65M | 0.02% |
+62,452
| New | +$3.65M |
|
100
Zevra Therapeutics
ZVRA
$501M
| $3.56M | 0.02% |
571,200
-11,061
| -2% | -$69K |
|